PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $27.5 million in its third quarter.
The Pleasanton, California-based company said it had a loss of 22 cents per share.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 27 cents per share.
The life science technology company posted revenue of $149 million in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $142.4 million.
For the current quarter ending in December, 10x Genomics said it expects revenue in the range of $154 million to $158 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
